Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Nothing does it for Thera

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Apr 15, 2024 7:48am

67 Views

Post# 35988890

RE:Nothing does it for Thera

They need to be merged with a good operator and have their pariah name erased from our memory if we ever want to get something for our gone investments. We are closing in on May 9 and like it says on my Qc licence plate.. Je me souviens....

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec